AN2 THERAPEUTICS, INC.

Analyst Reco. AN2 Therapeutics, Inc.

Equities

ANTX

US0373261058

Market Closed - Nasdaq Other stock markets 16:00:00 2024-06-24 EDT			5-day change	1st Jan Change
2.07 ^USD	-1.90%		0.00%	-89.90%

05-16	Evercore ISI Adjusts Price Target on AN2 Therapeutics to $2 From $7, Maintains In-Line Rating	MT
05-14	AN2 Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Evercore ISI Adjusts Price Target on AN2 Therapeutics to $2 From $7, Maintains In-Line Rating	05-16	MT
JMP Securities Upgrades AN2 Therapeutics to Market Outperform From Market Perform	04-02	MT
Leerink Partners Downgrades AN2 Therapeutics to Market Perform From Outperform, Adjusts PT to $7 From $23	02-13	MT
Oppenheimer Downgrades AN2 Therapeutics to Market Perform From Outperform	02-12	MT
Evercore ISI Downgrades AN2 Therapeutics to In Line from Outperform, Adjusts PT to $7 From $25	02-12	MT
JMP Securities Downgrades AN2 Therapeutics to Market Perform From Market Outperform	02-12	MT
JMP Securities Initiates AN2 Therapeutics With Market Outperform Rating, Price Target is $30	01-04	MT
Oppenheimer Adjusts AN2 Therapeutics Price Target to $27 From $24, Maintains Outperform Rating	23-09-14	MT
Oppenheimer Adjusts AN2 Therapeutics Price Target to $24 From $20, Maintains Outperform Rating	23-03-30	MT
Oppenheimer Adjusts AN2 Therapeutics Price Target to $20 From $22, Maintains Outperform Rating	22-11-10	MT
Evercore ISI Initiates Coverage on AN2 Therapeutics With Outperform Rating, $25 Price Target	22-04-19	MT
Oppenheimer Initiates Coverage on AN2 Therapeutics With Outperform Rating, $22 Price Target	22-04-19	MT
Cowen Starts AN2 Therapeutics at Outperform	22-04-19	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Our Free Content Help you Secure and Increase the Performance of Your Investments

Securing my Investments

fermer